Related by context. Frequent words. (Click for all words.) 61 placebo controlled Phase 59 Cloretazine R VNP#M 59 HER2 positive metastatic breast 59 Phase 1b 59 dose escalation trial 58 phase IIb clinical 58 primary hypercholesterolemia 58 sapacitabine 57 Phase 2a clinical 57 Phase 2a 57 multicenter randomized 57 metastatic hormone refractory 56 double blinded placebo 56 Phase 2a trial 56 Genasense R oblimersen 56 CR# vcMMAE 56 Phase Ib 56 R sorafenib tablets 56 relapsed refractory multiple myeloma 56 pivotal Phase 56 multiple ascending dose 56 multicenter randomized double 56 Pivotal Phase 56 phase IIa 55 anticancer compound 55 Acute Myeloid Leukemia AML 55 phase 2a 55 blinded placebo controlled 55 randomized Phase 55 metastatic renal cell carcinoma 55 randomized #:# 55 PRECiSE 55 Pivotal Phase III 55 Phase III randomized 55 diagnosed multiple myeloma 55 label dose escalation 55 Phase 2b clinical 54 Phase Ia 54 label multicenter 54 randomized Phase III 54 IIa trial 54 castration resistant prostate cancer 54 Panzem R 54 Researchers randomly assigned 54 HGS ETR1 54 Phase IIa trial 54 custirsen 54 Atiprimod 54 phase IIb 53 refractory multiple myeloma 53 randomized placebo controlled 53 Phase Ib clinical 53 sodium Injection 53 administered subcutaneously 53 deforolimus 53 IMC A# 53 nab paclitaxel 53 dose escalation study 53 dose escalation 53 ascending doses 53 plus gemcitabine 53 cutaneous T cell 53 Amrubicin 53 Phase 2b study 53 acute myelogenous leukemia AML 53 Phase IIb 53 DDP# 53 BAY #-# 53 Metastatic Melanoma 53 placebo controlled clinical 53 liposomal formulation 53 heavily pretreated 52 lymphoma CTCL 52 placebo controlled randomized 52 relapsed multiple myeloma 52 investigational compounds 52 advanced carcinoid 52 Phase IIa 52 randomized 52 Traficet EN 52 elotuzumab 52 Phase IIb clinical 52 PREZISTA r 52 KRN# 52 Phase 2b 52 dose cohorts 52 Phase IIa clinical 52 investigational oral 52 pazopanib 52 chlorambucil 52 patients undergoing percutaneous 52 Completes Enrollment 52 single ascending dose 51 Phenoptin 51 PRX # 51 Phase 1b clinical 51 RGB # 51 painful diabetic neuropathy 51 active comparator 51 registrational trial 51 dose titration